[ Price : $8.95]
Public Citizen sues FDA to force it to act on a six-year-old petition seeking labeling changes for SSRIs and SNRIs to highlight th...[ Price : $8.95]
FDA says the Hologic recall (correction) of BioZorb markers is Class 1.[ Price : $8.95]
Magellan Diagnostics (Billerica, MA) agrees to pay $40 million to resolve criminal charges relating to its concealment of a device...[ Price : $8.95]
PhRMA says it supports FDA and the International Council for Harmonization revision of the E2D guidance on post-approval case safe...[ Price : $8.95]
Federal Register notice: FDA announces a 7/11 public workshop entitled Evaluating Immunosuppressive Effects of In Utero Exposure t...[ Price : $8.95]
Federal Register notice: FDA reinstates an information collection entitled Yale-Mayo Clinic Centers of Excellence in Regulatory Sc...[ Price : $8.95]
FDA warns Gaithersburg, MD-based Akan Biosciences about multiple violations in its manufacturing and distribution of Ayama, an adi...[ Price : $8.95]
GSK says two Phase 3 clinical trials evaluating severe asthma treatment hopeful depemokimab met their primary endpoints of reducin...